wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38872239-88B0C2A6-D935-449C-9C87-1449B6B57C7F
Q38872239-88B0C2A6-D935-449C-9C87-1449B6B57C7F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38872239-88B0C2A6-D935-449C-9C87-1449B6B57C7F
Anti-angiogenic agents in ovarian cancer: past, present, and future.
P2860
Q38872239-88B0C2A6-D935-449C-9C87-1449B6B57C7F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38872239-88B0C2A6-D935-449C-9C87-1449B6B57C7F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
76c898821f43dc23a3317a245590a63299950c3e
P2860
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).